Aminex Therapeutics, Inc. Is Awarded Qualifying Therapeutic Discovery Project (QTDP) Grant
SEATTLE, WA–(Marketwire – 11/09/10) – Aminex Therapeutics, a drug research and development company focused on the treatment of cancer, announced today that it has been awarded a grant totaling $ 244,479 by the US Department of Treasury’s Qualified Therapeutic Discovery Program (QTDP). The Internal Revenue Service’s QTDP grant will advance the development of Aminex Therapeutics’ optimized lead …
Read more on Marketwire via Yahoo! Finance
Major Clinical Trial Prompts Call For Change To Treatment Guidelines For Severe Malaria Worldwide
The largest ever clinical trial in patients hospitalised with severe malaria has concluded that the drug artesunate should now be the preferred treatment for the disease in both children and adults everywhere in the world. The study, funded by the Wellcome Trust, is published today online in the journal The Lancet. An international consortium of researchers, led by Professor Nick White of the …
Read more on redOrbit
Kombiglyze™ Xr (Saxagliptin And Metformin Hcl Extended-Release) Tablets Approved In The U.S. For The Treatment Of Type …
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment of type 2 diabetes in adults. KOMBIGLYZE XR is the first and only once-a-day metformin extended-release (XR) plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet offering strong glycemic control across glycosylated …
Read more on Medical News Today